Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel—An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin
The simultaneous encapsulation of drugs into nanosized delivery systems could be beneficial for cancer therapies since it could alleviate adverse reactions as well as provide synergistic effects. However, the encapsulation of hydrophobic drugs into hydrophilic nanoparticles, such as nanogels, could...
Saved in:
| Main Authors: | Lyubomira Radeva, Yordan Yordanov, Ivanka Spassova, Daniela Kovacheva, Virginia Tzankova, Krassimira Yoncheva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Gels |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2310-2861/10/11/699 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histopathological evaluation of the effects of thymoquinone and resveratrol on the liver in rats administered doxorubicin
by: Mehmet Burak Ates, et al.
Published: (2022-09-01) -
Resveratrol—A Promising Therapeutic Agent with Problematic Properties
by: Lyubomira Radeva, et al.
Published: (2025-01-01) -
Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer
by: Xiaoxia Jin, et al.
Published: (2019-03-01) -
Influence de l’hydroxypropyl-β-Cyclodextrine et de l’hydroxypropyl-γ-Cyclodextrine sur la solubilité aqueuse de l’acide ellagique
by: Isaie Nyamba, et al.
Published: (2024-12-01) -
Using Poly(amidoamine) PAMAM-βCD Dendrimer for Controlled and Prolonged Delivery of Doxorubicin as Alternative System for Cancer Treatment
by: Kendra Sorroza-Martínez, et al.
Published: (2024-11-01)